AcouSort AB (publ) (ACOU.ST) Research
AcouSort AB (publ) is a technology firm that innovates and provides automated systems for preparing biological samples. Their core methodology relies on acoustofluidics technology, catering to the needs of the research community and various life science organizations. The company's product portfolio includes several key offerings: AcouTrap: A compact laboratory instrument engineered for preparing samples containing cells, extracellular vesicles, bacteria, and viruses from diverse biological media. AcouPlasma: An integrated module capable of separating blood plasma directly from whole blood, enabling seamless in-line analytical processes. AcouWash: Another benchtop device designed for the label-free isolation of specific target cells from a wide array of samples. Established in 2010, AcouSort is headquartered in Lund, Sweden.
Market snapshot
- Symbol
- ACOU.ST
- Price
- $4.18
- Day change
- -1.42%
- Market cap
- $88.5M
- P/E ratio
- -8.53x
- 52-week range
- 2.03-5.16
- Sector
- Healthcare
- Industry
- Biotechnology
Peer companies
- Alligator Bioscience AB (publ) (ATORX.ST)
- ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
- Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
- Modus Therapeutics Holding AB (publ) (MODTX.ST)
- Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
- OncoZenge AB (publ) (ONCOZ.ST)
- Ortivus AB (publ) (ORTI-B.ST)
- Simris Alg AB (publ) (SIMRIS-B.ST)
Open AcouSort AB (publ) (ACOU.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.